NCT02033629View on ClinicalTrials.gov

Low Remifentanil Target Controlled Infusions for Cardiac Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 1, 2019

Study Completion Date

May 15, 2019

Conditions
Cardiac Surgery
Interventions
DRUG

Ce 1 ng/ml

TCI Remifentanil Ce 1 ng/ml

DRUG

Ce 2 ng/ml

TCI Remifentanil Ce 2 ng/ml

DRUG

Ce 3 ng/ml

TCI Remifentanil Ce 3 ng/ml

Trial Locations (1)

31952

Dammam University, Khobar

All Listed Sponsors
lead

Imam Abdulrahman Bin Faisal University

OTHER

NCT02033629 - Low Remifentanil Target Controlled Infusions for Cardiac Surgery | Biotech Hunter | Biotech Hunter